➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Medtronic
Merck
Harvard Business School
Mallinckrodt

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

AFEDITAB CR Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Afeditab Cr, and what generic alternatives are available?

Afeditab Cr is a drug marketed by Watson Labs and Watson Labs Teva and is included in two NDAs.

The generic ingredient in AFEDITAB CR is nifedipine. There are thirty-nine drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the nifedipine profile page.

US ANDA Litigation and Generic Entry Outlook for Afeditab Cr

A generic version of AFEDITAB CR was approved as nifedipine by ACTAVIS ELIZABETH on September 20th, 1990.

  Start Trial

US Patents and Regulatory Information for AFEDITAB CR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs AFEDITAB CR nifedipine TABLET, EXTENDED RELEASE;ORAL 075659-001 Oct 26, 2001 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs Teva AFEDITAB CR nifedipine TABLET, EXTENDED RELEASE;ORAL 075128-001 Mar 10, 2000 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Colorcon
Johnson and Johnson
Express Scripts
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.